Supernus Pharmaceuticals, Inc. $SUPN Stock Holdings Lowered by JPMorgan Chase & Co.

JPMorgan Chase and Co. trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) by 45.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 171,285 shares of the specialty pharmaceutical company's stock after selling 143,816 shares during the period. JPMorgan Chase